A Case of Cutaneous Plasmacytoma Treated with Bortezomib and Radiotherapy / 대한피부과학회지
Korean Journal of Dermatology
; : 483-486, 2009.
Article
в Ko
| WPRIM
| ID: wpr-124177
Ответственная библиотека:
WPRO
ABSTRACT
Multiple myeloma is a hematologic malignancy characterized by the proliferation of monoclonal plasma cells that produce monoclonal immunoglobulins. Cutaneous involvement is very uncommon in patients with multiple myeloma. It usually appears late in the course of the disease. Bortezomib is a potent proteasome inhibitor, recently introduced in the treatment of multiple myeloma. It has proven to be safe and effective in the treatment of refractory or relapsed multiple myeloma. In this study, we show the high efficacy of a concurrent therapeutic approach with bortezomib and radiation in a patient with a cutaneous plasmacytoma.
Key words
Полный текст:
1
База данных:
WPRIM
Основная тема:
Plasma Cells
/
Plasmacytoma
/
Pyrazines
/
Boronic Acids
/
Immunoglobulins
/
Hematologic Neoplasms
/
Proteasome Inhibitors
/
Bortezomib
/
Multiple Myeloma
Пределы темы:
Humans
Язык:
Ko
Журнал:
Korean Journal of Dermatology
Год:
2009
Тип:
Article